BiondVax, Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate, company announcement, October 2020 (the sponsor's own release)

Cited by name. No followable URL — the bibliographic record is the citation.

Authors. BiondVax

Venue. company announcement, October 2020 (the sponsor's own release)

How the Institute flags it

established 1 time

Cited on 1 page

• Universal Vaccines